- HealthTech
- Monday, 18 May 2020
Philips Healthcare US to Include SyntheticMR's Solution in Product Catalogue
"Healthcare providers in North America through this collaboration will now have quicker access to a solution that can help shorten scan times, improve patient throughput and provide quantitative data, which will be critical in post COVID-19 times," says Kyle Frye, President SyntheticMR Inc. "I am excited to accelerate our growth on the US market together with Philips Healthcare and for their sales team to begin selling our product by mid-June."
Philips Healthcare currently offers the quantitative sequence SyntAc as an option to their customers, and adding SyntheticMR's software solution enables the customer to generate multiple contrast-weighted images and volumetric data in a single 5-6 minute scan. SyntheticMR's product is compatible with most MRI scanners from Philips Healthcare.
"Philips Healthcare is an important partner in our ambitions to provide customers with workflow improvements and objective decision support," says Ulrik Harrysson, CEO, SyntheticMR AB. "This agreement is an important step for a closer collaboration with Philips Healthcare on a global level."
Related Industry Updates
Recent research: Healthcare Cloud Computing Market highly favorable to the growth rate by 2027
Mar 23, 2021
South and Central America RNAi Therapeutics Market is Ready to reach US$ 38.70 million by 2027| Business Market Insights
Mar 09, 2021
Epion Health Responds to COVID-19 Pandemic with Free Software Platform
Apr 21, 2020
Open MRI Systems Market Proclivities Reveal Increased Contribution by Leading Players towards Revenue Growth
Dec 07, 2020
Worldwide Opportunities In Next-generation Antibody Market 2021 With Market Size, Growth Till 2027
Mar 15, 2021
Asia Pacific Bioactive Wound Management Market Strategies, Types and Application, Forecast during 2019- 2027 | Smith & Nephew, Hartman Group, Coloplast Group
Jan 12, 2021
Rapid developments Knocking in North America Tooth Positioner Market is estimated to grow at a CAGR of 46% from 2020 to 2027
Mar 09, 2021